Authors: Wiltshire, HR Prior, KJ Dhesi, J Maile, G

Citation: Hr. Wiltshire et al., The synthesis of labelled forms of cipemastat, J LABEL C R, 44(2), 2001, pp. 149-164

Authors: Huisman, MT Smit, JW Wiltshire, HR Hoetelmans, RMW Beijnen, JH Schinkel, AH

Citation: Mt. Huisman et al., P-glycoprotein limits oral availability, brain, and fetal penetration of saquinavir even with high doses of ritonavir, MOLEC PHARM, 59(4), 2001, pp. 806-813

Authors: Washington, CB Wiltshire, HR Man, M Moy, T Harris, SR Worth, E Weigl, P Liang, ZM Hall, D Marriott, L Blaschke, TF

Citation: Cb. Washington et al., The disposition of saquinavir in normal and P-glycoprotein deficient mice,rats, and in cultured cells, DRUG META D, 28(9), 2000, pp. 1058-1062

Authors: Wiltshire, HR Wiltshire, BG Clarke, AF Worth, E Prior, KJ Tjia, JF

Citation: Hr. Wiltshire et al., Chromatographic and immunochemical approaches to the analysis of the HIV protease inhibitor saquinavir in plasma, ANALYT BIOC, 281(1), 2000, pp. 105-114

Authors: Smit, JW Huisman, MT van Tellingen, O Wiltshire, HR Schinkel, AH

Citation: Jw. Smit et al., Absence or pharmacological blocking of placental P-glycoprotein profoundlyincreases fetal drug exposure, J CLIN INV, 104(10), 1999, pp. 1441-1447

Authors: Wiltshire, HR Prior, KJ Dhesi, J Trach, F Schlageter, M Schonenberger, H

Citation: Hr. Wiltshire et al., The synthesis of labelled forms of saquinavir, J LABEL C R, 41(12), 1998, pp. 1103-1126